Aspirin use and the risk of gastric cancer: A meta-analysis

Digestive Diseases and Sciences

Volumn 55, Issue 6, 2010, Pages 1533-1539

  Yang, Ping ^a   Zhou, Yong ^a   Chen, Bo ^a   Wan, Hong Wei ^a   Jia, Gui Qing ^a   Bai, Hai Long ^a   Wu, Xiao Ting ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Aspirin; Gastric cancer; Helicobacter pylori; Meta analysis

Indexed keywords

ACETYLSALICYLIC ACID;

CANCER RISK; CAUCASIAN; EMBASE; GENDER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; STOMACH CANCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; EVIDENCE-BASED MEDICINE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

EID: 77954427051     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0915-0     Document Type: Review

References (49)

1. DM Paking F Bray J Ferlay P Pissani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 (Pubitemid 40372904)
2. H Brenner D Rothenbacher V Arndt 2009 Epidemiology of stomach cancer Methods Mol Biol 472 467 477 10.1007/978-1-60327-492-0-23 19107449
3. RW Clapp MM Jacobs EL Loechler 2008 Environment and occupational cause of cancer: new evidence 2005-2007 Rev Environ Health 23 1 37 1:CAS:528: DC%2BD1cXntVOmu7Y%3D 18557596
4. HY Lim HJ Joo JW Yi, et al. 2000 Increased expression of cyclooxygenase-2 protein in human gastric carcinoma Clin Cancer Res 6 519 525 1:CAS:528:DC%2BD3cXhs1aktr4%3D 10690533 (Pubitemid 30111473)
5. YE Joo IJ Chung YS Park, et al. 2006 Expression of cyclooxygenase-2, p53 and ki-67 in gastric cancer J Korean Med Sci 21 871 876 10.3346/jkms.2006.21.5. 871 1:CAS:528:DC%2BD28Xht1eit7nP 17043422 (Pubitemid 44611222)
6. Q Tong G Wang X Lu K Tao D Chen 2006 Expression and clinical significance of nuclear factor-kB and cyclooxygenase-2 in gastric carcinoma tissue Chin J Gastroenterol 11 160 163 (Pubitemid 44596300)
7. L Hou P Grillo ZZ Zhu, et al. 2007 COX-1 and COX-2 polymorphisms and gastric cancer risk in a Polish population Anticancer Res 27 4234 4247 (Pubitemid 44942634)
8. MJ Redlak JJ Power TA Miller 2007 Aspirin-induced apoptosis in human gastric cancer epithelial cells: relationship with protein kinase C signaling Dig Dis Sci 52 810 816 10.1007/s10620-006-9577-3 1:CAS:528:DC%2BD2sXhslWjurc%3D 17253132 (Pubitemid 46303081)
9. H Sawaoka S Tsuji M Tsujii, et al. 1999 Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo Lab Invest 79 1469 1477 1:CAS:528:DC%2BD3cXlsVCksg%3D%3D 10616198 (Pubitemid 30013912)
10. M Oba K Miwa T Fujimura S Harada S Sasaki T Hattori 2008 Chemoprevention of glandular stomach carcinogenesis through duodenogastric reflux in rats by a COX-2 inhibitor Int J Cancer 123 1491 1498 10.1002/ijc.23742 1:CAS:528:DC%2BD1cXhtV2ru77P 18646190
11. NJ Shaheen WL Straus RS Sandler 2002 Chemoprevention of gastrointestinal malignancies with non-steroidal anti-inflammatory drugs Cancer 94 950 963 10.1002/cncr.10333 1:CAS:528:DC%2BD38XitVKhs7o%3D 11920463 (Pubitemid 34150849)
12. MJ Redlak JJ Power TA Miller 2008 Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kB and PKC signaling J Surg Res 145 66 73 10.1016/j.jss.2007.04.039 1:CAS:528:DC%2BD1cXitVeiu78%3D 17644113 (Pubitemid 351222735)
13. K Jolly KK Cheng MJ Langman 2002 NSAIDs and gastrointestinal cancer prevention Drugs 62 945 956 10.2165/00003495-200262060-00006 1:CAS:528:DC%2BD38XjvFGntbY%3D 11929340 (Pubitemid 34454620)
14. SS Husain IL Szabo AS Tamawski 2002 NSAIDs inhibition of GI cancer growth: clinical implications and molecular mechanisms of action Am J Gastroenterol 97 542 553 10.1111/j.1572-0241.2002.05528.x 1:CAS:528: DC%2BD38XjtFyrs70%3D 11922545
15. MD Gammon MB Terry N Arber, et al. 2004 Non-steroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of esophagus and gastric cardia that over express cyclin D1: a population-based study Cancer Epidemiol Biomark Prev 13 34 39 10.1158/1055-9965.EPI-03-0198 1:CAS:528:DC%2BD2cXmsVWgtg%3D%3D (Pubitemid 38116618)
16. HJ Hwang YH Youn JH Kim JB Chung YC Lee 2006 Low-dose aspirin affects the clinicopathological features of gastric cancer Digestion 73 54 59 10.1159/000092248 1:CAS:528:DC%2BD28XjvFSmtrg%3D 16554658 (Pubitemid 43800662)
17. PJF Jonge LMM Wolters EW Steyerberg, et al. 2007 Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in Dutch cohort Aliment Pharmacol Ther 26 31 39
18. M Giliies A Skyring 1968 Gastric ulcer, duodenal ulcer and gastric carcinoma: a case-control study of certain social and environmental factors Med J Aust 2 1132 1136
19. MJ Thun MM Namboodiri EE Calle WD Flanders CW Health Jr 1993 Aspirin use and risk of fatal cancer Cancer Res 53 1322 1327 1:CAS:528:DyaK3sXktl2qtLY%3D 8443812 (Pubitemid 23097110)
20. DM Schreinemachers RB Everson 1994 Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 138 146 10.1097/00001648-199403000-00003 1:STN:280:DyaK2c3islWmsw%3D%3D 8172988
21. DC Farrow TL Vaughan PD Hansten, et al. 1998 Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer Cancer Epidemiol Biomark Prev 7 97 102 1:CAS:528:DyaK1cXhtlSmsrk%3D
22. D Zaridze E Borisova D Maximovitich V Chkhikvadze 1999 Aspirin protects against gastric cancer: result of a case-control study from Moscow, Russia Int J Cancer 82 473 476 10.1002/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3. 0.CO;2-K 1:CAS:528:DyaK1MXltVKqsbo%3D 10404057 (Pubitemid 29343443)
23. K Akre AM Ekstrom LB Signorello LE Hansson O Nyren 2001 Aspirin and risk for gastric cancer: a population-based case-control study in Sweden Br J Cancer 84 965 968 10.1054/bjoc.2001.1702 1:CAS:528:DC%2BD3MXktVejsr8%3D 11286478 (Pubitemid 32385841)
24. LD Ratnasinghe BI Graubard L Kahle JA Tangrea PR Taylor E Hawk 2004 Aspirin use and mortality from cancer in a prospective cohort study Anticancer Res 24 3177 3184 15510608 (Pubitemid 39390970)
25. M Lindblad J Lagergren LA García Rodríguez 2005 Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer Cancer Epidemiol Biomark Prev 14 444 450 10.1158/1055-9965.EPI-04-0467 1:CAS:528:DC%2BD2MXhs1GhsLo%3D (Pubitemid 40270110)
26. NR Cook IM Lee JM Gaziano, et al. 2005 Low-dose aspirin in the primary prevention of cancer: the women's health study: a randomized controlled trial JAMA 294 47 55 10.1001/jama.294.1.47 1:CAS:528:DC%2BD2MXlvVKnt7Y%3D 15998890 (Pubitemid 41002838)
27. J Fortuny C Johnson K Bohlke, et al. 2007 Use of anti-inflammatory drugs and lower esophageal sphincter relaxing drugs and risk of esophageal and gastric cancers Clin Gastroenterol Hepatol 5 1154 1159 10.1016/j.cgh.2007.05.022 17644046 (Pubitemid 47488964)
28. L Duan AH Wu J Sullivan Halley L Bernstein 2008 Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County Cancer Epidemiol Biomark Prev 17 126 134 10.1158/1055-9965. EPI-07-0664 1:CAS:528:DC%2BD1cXmt12itg%3D%3D (Pubitemid 351196282)
29. S Sadeghi CJ Bain N Pandeya PM Webb AC Green DC Whiteman 2008 Aspirin, non-steroidal anti-inflammatory drugs, and the risks of cancers of the esophagus Cancer Epidemiol Biomark Prev 17 1169 1178 10.1158/1055-9965.EPI-07-2852 1:CAS:528:DC%2BD1cXmtVClsbo%3D
30. CC Abnet ND Freendman F Kamangar MF Leitzmann AR Hollenbeck A Schatzkin 2009 Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis Br J Cancer 100 551 557 10.1038/sj.bjc.6604880 1:CAS:528:DC%2BD1MXhsFektr0%3D 19156150
31. JD Figueroa MB Terry MD Gammon, et al. 2009 Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression Cancer Causes Control 20 361 368 10.1007/s10552-008-9250-6 18989634
32. GA Kune S Kune LF Watson 1988 Colorectal cancer risk, chronic illnesses, operations and medication: case-control results from the Melbourne Colorectal Cancer Study Cancer Res 48 4399 4404 1:STN:280:DyaL1c3ntVequg%3D%3D 3390835
33. S Mangiapane M Blettner P Schlattmann 2008 Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005 Pharmacoepidemiol Drug Saf 17 115 124 10.1002/pds.1503 17955496 (Pubitemid 351308510)
34. B Takkouche C Regueira-Méndez M Etminan 2008 Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis J Natl Cancer Inst 100 1439 1447 10.1093/jnci/djn324 1:CAS:528:DC%2BD1cXht1Oisb7I 18840819
35. E Liu LC Sakodal YT Gao, et al. 2005 Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China Cancer Epidemiol Biomark Prev 14 1315 1318 10.1158/1055-9965.EPI-05-0032 1:CAS:528: DC%2BD2MXktFCktb0%3D (Pubitemid 40656488)
36. K Dasgupta D Di Cesar J Ghosn R Rajan S Mahmud E Rahme 2006 Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence Cancer J 12 130 135 1:CAS:528:DC%2BD28XkslKrt7w%3D 16630404
37. AL Van Dyke ML Cote G Prysak GB Claeys AS Wenzlaff AG Schwartz 2008 Regular adult aspirin use decreases the risk of non-small cell lung cancer among women Cancer Epidemiol Biomark Prev 17 148 157 10.1158/1055-9965.EPI-07-0517 (Pubitemid 351196285)
38. TG Morales 1997 Adenocarcinoma of the gastric cardia Dig Dis 15 346 356 10.1159/000171610 1:STN:280:DyaK1c7gtlSksQ%3D%3D 9439899
39. H Maeda T Okabayashi I Nishimori, et al. 2008 Clincopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg 206 306 310 10.1016/j.jamcollsurg.2007.06.306 18222384
40. F Kamangar SM Dawsey MJ Blaser, et al. 2006 Opposing risk of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity J Natl Cancer Inst 98 1445 1452 17047193 (Pubitemid 44605589)
41. M Tatemichi S Sasazuki M Inoue S Tsugane 2008 Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nest case-control study using IgG titer against Hp surface antigen Acta Oncol 47 360 365 10.1080/02841860701843035 1:CAS:528:DC%2BD1cXjtlWhtbc%3D 18347999 (Pubitemid 351414940)
42. NJ Tally 2008 Is it time to screen, treat H. pylori to prevent gastric cancer? Lancet 372 350 352 10.1016/S0140-6736(08)61136-8
43. WH Wang WM Wong D Dailidiene, et al. 2003 Aspirin inhibits the growth of Helicobacter pylori enhances its susceptibility to antimicrobial agents Gut 52 490 495 10.1136/gut.52.4.490 1:CAS:528:DC%2BD3sXjtVKltLo%3D 12631656 (Pubitemid 36363398)
44. M Takahashi Y Katayama H Takada H Kuwayama A Terano 2004 The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts Aliment Pharmacol Ther 14 Suppl 1 44 49 (Pubitemid 30199104)
45. S Wacholder JK Mclaughlin DT Silverman JS Mandel 1992 Selection of controls in case-control studies I. Principles Am J Epidemiol 135 1019 1028 1:STN:280:DyaK383otVOqtQ%3D%3D 1595688
46. RE Patterson ML Neuhouser E White JR Hunt AR Kristal 1998 Cancer-related behavior of vitamin supplement users Cancer Epidemiol Biomark Prev 7 79 81 1:STN:280:DyaK1c7hsFOrsw%3D%3D (Pubitemid 28087145)
47. DA Sample PS Sinicrope MJ Wargovich FA Sinicrope 2002 Post-study aspirin intake and factors motivating participation in a colorectal cancer chemoprevention trial Cancer Epidemiol Biomark Prev 11 281 285 1:CAS:528:DC%2BD38XivFyhsrc%3D
48. I Ryár M Hlísta P Masark, et al. 2006 Gastroduodenal complication associated with non-steroidal anti-inflammatory drugs in Slovak Republic: result of one-year prospective study Vnitr Lek 52 673 676
49. S Ishikawa T Inaba M Mizuno, et al. 2008 Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan Acta Med Okayama 62 29 36 18323869 (Pubitemid 351463555)